Abivax (ABVX) Interest & Investment Income (2024 - 2026)

Abivax's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $14.9 million for Q1 2026.

• On a quarterly basis, Interest & Investment Income rose 815.0% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $48.3 million, a 262.41% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 115.73% from the prior year.
• Interest & Investment Income rose to $14.9 million in Q1 2026 per ABVX's latest filing, from $5.6 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $23.9 million in Q3 2025 and bottomed at $1.6 million in Q1 2025.
• The 3-year median for Interest & Investment Income is $4.0 million (2024), against an average of $7.6 million.
• Across the five-year window, Interest & Investment Income slumped 75.08% in 2025 and soared 815.0% in 2026, its largest moves.
• Year by year, Interest & Investment Income stood at $4.0 million in 2024, then surged by 38.27% to $5.6 million in 2025, then soared by 167.23% to $14.9 million in 2026.
• Per Business Quant, the three latest ABVX Interest & Investment Income figures stand at $14.9 million (Q1 2026), $5.6 million (Q4 2025), and $23.9 million (Q3 2025).